Firms
Redmile Group
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.
Team
No team members on record yet.
Co-investing
ARCH Venture Partners
Prime Medicine, Inc.$200M · 2021-07-13
OncoResponse, Inc.$40M · 2021
OncoResponse, Inc.$40M · 2018-09-11
OncoResponse$40M · 2018-09-11
Syros Pharmaceuticals$53M · 2014-10-27
Cormorant Asset Management
Neurogene$95M · 2023-12-18
Prime Medicine, Inc.$200M · 2021-07-13
Neurogene$115M · 2020-12-16
Neurogene$68M · 2019-02-12
Ovid Therapeutics$75M · 2015-08-11
Samsara BioCapital
Neurogene$200M · 2024-11-04
Neurogene$95M · 2023-12-18
Prime Medicine, Inc.$200M · 2021-07-13
Neurogene$115M · 2020-12-16
Neurogene$68M · 2019-02-12
Alexandria Venture Investments
Neurogene$95M · 2023-12-18
Neurogene$115M · 2020-12-16
OncoResponse, Inc.$40M · 2018-09-11
OncoResponse$40M · 2018-09-11
Casdin Capital
Neurogene$200M · 2024-11-04
Neurogene$95M · 2023-12-18
Prime Medicine, Inc.$200M · 2021-07-13
Neurogene$115M · 2020-12-16
Fidelity Management & Research Company
- Saluda Medical$100M · 2025-01-17
- Saluda Medical$150M · 2023-04-13
- Saluda Medical$125M · 2022-03-02
Ovid Therapeutics$75M · 2015-08-11
Canaan Partners
OncoResponse, Inc.$40M · 2021
OncoResponse, Inc.$40M · 2018-09-11
OncoResponse$40M · 2018-09-11
RiverVest Venture Partners
OncoResponse, Inc.$40M · 2021
OncoResponse, Inc.$40M · 2018-09-11
OncoResponse$40M · 2018-09-11
T. Rowe Price
- Saluda Medical$100M · 2025-01-17
- Saluda Medical$150M · 2023-04-13
- Saluda Medical$125M · 2022-03-02
Action Potential Venture Capital
- Saluda Medical$100M · 2025-01-17
- Saluda Medical$150M · 2023-04-13
Qatar Investment Authority
OncoResponse, Inc.$40M · 2018-09-11
OncoResponse$40M · 2018-09-11
Wellington Management
- Saluda Medical$100M · 2025-01-17
- Saluda Medical$150M · 2023-04-13
3B Future Health Fund
OncoResponse, Inc.$40M · 2021
Commodore Capital
Neurogene$200M · 2024-11-04
Cowen Healthcare Investments
Ovid Therapeutics$75M · 2015-08-11
F-Prime Capital
Prime Medicine, Inc.$200M · 2021-07-13
GV
Prime Medicine, Inc.$200M · 2021-07-13
HBM Healthcare Investments
Genalyte$50M · 2021-01-11
Jennison Associates
Ovid Therapeutics$75M · 2015-08-11
Magnetar Capital
OncoResponse, Inc.$40M · 2021
Moore Strategic Ventures
Prime Medicine, Inc.$200M · 2021-07-13
Newpath Partners
Prime Medicine, Inc.$200M · 2021-07-13
Piper Heartland
- Saluda Medical$100M · 2025-01-17
Polaris Partners
Syros Pharmaceuticals$53M · 2014-10-27
Provenio Capital
Genalyte$50M · 2021-01-11
PSP Investments
Prime Medicine, Inc.$200M · 2021-07-13
RTW Investments, LP
Neurogene$200M · 2024-11-04
Sanofi Ventures
Ovid Therapeutics$75M · 2015-08-11
T. Rowe Price Associates
Prime Medicine, Inc.$200M · 2021-07-13
Tekla Capital Management
Ovid Therapeutics$75M · 2015-08-11
TPG
- Saluda Medical$150M · 2023-04-13
TPG Life Sciences
- Saluda Medical$100M · 2025-01-17


